Cost-Effectiveness evaluation of Ambulatory and Hospital Care for MDR-TB Treatment in Pakistan: A Randomized Controlled Trial.
Keywords:
Cost-effectiveness, DALYs, Ambulatory care, Hospital Care, MDR-TB, Pakistan.Abstract
The rank of Pakistan is fourth in the high multidrug resistance tuberculosis (MDR-TB) burden countries. To combat the disease in a resource-scarce setting, it is important to explore treatment regimens that are safe, efficient, and cost-effective. A decision tree model is employed for cost-effectiveness analysis (CEA) of treatment arms, quantifying their value through incremental costeffectiveness ratios (ICER). In 2012-2017, randomized control trials were conducted in Lahore, Murree, and Karachi comparing two MDR-TB treatment care arms by collecting the data of 342 newly diagnosed patients. The results show that continuous dominance is not depicted by either arm while both demonstrated their value in reducing the disease burden for MDR-TB patients in Pakistan. Hence both approaches can be simultaneously considered viable strategies for treatment.
Downloads
Published
Issue
Section
License
So that authors and publisher may be protected from the consequences of unauthorized use of the contents published in IJME, we require, as a condition of publication, that authors assign us all rights, including subsidiary rights, to their work. This enables us to promote and distribute the contribution in professionally appropriate venues. Authors have nonexclusive license to use their work without charge and without further permission after it has been published by IJME, as long as the IJME publication is referenced.